Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy

✍ Scribed by John Marshall; Kerry Anne McEachern; Wei-Lien Chuang; Elizabeth Hutto; Craig S. Siegel; James A. Shayman; Greg A. Grabowski; Ronald K. Scheule; Diane P. Copeland; Seng H. Cheng

• Publisher: Springer
• Year: 2010
• Tongue: English
• Weight: 367 KB
• Volume: 33
• Category: Article
• ISSN: 0141-8955
• DOI: 10.1007/s10545-010-9072-z